Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study
BackgroundAsparaginase-associated pancreatitis (AAP) is one of the most common complications occurring in patients with asparaginase-treated acute lymphoblastic leukemia (ALL). Peg-asparaginase (peg-asp), a chemically recombined asparaginase with lower hyposensitivity and better patient tolerance, i...
Main Authors: | Yun-yu Zhang, Qiu-shi Yang, Xia Qing, Bi-ru Li, Juan Qian, Ying Wang, Bo-tao Ning |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.538779/full |
Similar Items
-
Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia
by: Ana Paula Battistel, et al.
Published: (2021-01-01) -
Pancreatitis in adult with acute lymphoblastic leukemia using L-asparaginase and simvastatin: case report and systematic review
by: Renne Rodrigues, et al.
Published: (2016-02-01) -
Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase
by: Patel Zeeshan Jameel, et al.
Published: (2020-05-01) -
Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study
by: Liu T, et al.
Published: (2018-10-01) -
Severe L-asparaginase-induced Hypertriglyceridaemia Treated with Plasmapheresis
by: José Silvano, et al.
Published: (2021-02-01)